Chunrui Li

4.1k total citations · 1 hit paper
134 papers, 2.0k citations indexed

About

Chunrui Li is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Chunrui Li has authored 134 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 46 papers in Molecular Biology and 43 papers in Hematology. Recurrent topics in Chunrui Li's work include CAR-T cell therapy research (49 papers), Multiple Myeloma Research and Treatments (24 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Chunrui Li is often cited by papers focused on CAR-T cell therapy research (49 papers), Multiple Myeloma Research and Treatments (24 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Chunrui Li collaborates with scholars based in China, United States and Czechia. Chunrui Li's co-authors include Liancun Zheng, Shihao Han, Xinxin Zhang, Jianfeng Zhou, Di Wang, Min Xiao, Xia Mao, Liang Huang, Jue Wang and Liting Chen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Chunrui Li

119 papers receiving 1.9k citations

Hit Papers

Coupled flow and heat transfer in viscoelastic fluid with... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Coupled flow and heat transfer in viscoelastic fluid with Cattaneo–Christov heat flux model
    2014 392 citations Chunrui Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunrui Li China 23 704 694 485 412 322 134 2.0k
Hongchang Li China 28 578 0.8× 174 0.3× 1.7k 3.5× 107 0.3× 83 0.3× 93 2.7k
Cuicui Li China 25 172 0.2× 294 0.4× 715 1.5× 83 0.2× 20 0.1× 105 1.9k
Mohsen Eshraghi United States 16 192 0.3× 84 0.1× 602 1.2× 451 1.1× 211 0.7× 27 1.6k
He Liu China 22 510 0.7× 419 0.6× 764 1.6× 150 0.4× 20 0.1× 60 2.1k
Jörg C. Gerlach United States 32 156 0.2× 875 1.3× 760 1.6× 215 0.5× 24 0.1× 102 3.0k
Lu Xu China 24 245 0.3× 128 0.2× 566 1.2× 213 0.5× 91 0.3× 47 1.4k
Eleftherios T. Papoutsakis United States 33 212 0.3× 1.4k 2.0× 2.2k 4.5× 16 0.0× 59 0.2× 92 3.3k
Tao Ren China 28 259 0.4× 52 0.1× 1.1k 2.2× 122 0.3× 75 0.2× 79 2.2k
Guansong Wang China 28 125 0.2× 224 0.3× 1.4k 2.9× 42 0.1× 28 0.1× 109 2.2k

Countries citing papers authored by Chunrui Li

Since Specialization
Citations

This map shows the geographic impact of Chunrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunrui Li more than expected).

Fields of papers citing papers by Chunrui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunrui Li. The network helps show where Chunrui Li may publish in the future.

Co-authorship network of co-authors of Chunrui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chunrui Li. A scholar is included among the top collaborators of Chunrui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunrui Li. Chunrui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yi, Jibo Long, & Chunrui Li. (2025). Knowledge distillation for object detection with diffusion model. Neurocomputing. 636. 130019–130019.
2.
Wang, Jue, Na Wang, Jinhuan Xu, et al.. (2025). Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL. Blood Cancer Discovery. 7(1). 142–153.
3.
4.
Gao, Yang, Di Wang, & Chunrui Li. (2025). Harnessing Cellular Immunotherapy for EBV‐Associated Malignancies: Current Advances and Future Directions. Journal of Cellular and Molecular Medicine. 29(10). e70603–e70603. 1 indexed citations
5.
He, Jiawei, Tao Wu, Feng Wu, et al.. (2025). Traditional Chinese exercises for the treatment of neuropsychiatric symptoms in Parkinson’s disease: A systematic review and meta-analysis. Complementary Therapies in Medicine. 89. 103134–103134.
6.
Li, Chunrui, Dehui Zou, He Huang, et al.. (2024). Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study. Blood. 144(Supplement 1). 4761–4761. 2 indexed citations
7.
Chang, Zhen, Junqing Sun, Gen Zhang, et al.. (2024). Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model. Proceedings of the National Academy of Sciences. 121(24). 12 indexed citations
8.
Wang, Hongxi, et al.. (2024). Research on low voltage current transformer power measurement technology in the context of cloud computing. International Journal of Data Mining and Bioinformatics. 28(3/4). 287–302.
9.
Long, Xiaolu, Ning An, Chunhui Li, et al.. (2024). Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapy. Frontiers in Medicine. 11. 1363805–1363805. 1 indexed citations
10.
Tian, Dai‐Shi, Chuan Qin, Ming‐Hao Dong, et al.. (2024). B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis. EMBO Molecular Medicine. 16(4). 966–987. 30 indexed citations
11.
Qin, Chuan, Ming‐Hao Dong, Luo‐Qi Zhou, et al.. (2024). Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy. Proceedings of the National Academy of Sciences. 121(6). e2315990121–e2315990121. 42 indexed citations
12.
Xu, Yanjie, Xia Mao, Yimei Que, et al.. (2023). The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma. BMC Cancer. 23(1). 123–123. 5 indexed citations
13.
Wang, Na, Gaoxiang Wang, Liang Huang, et al.. (2022). CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation. Cytotherapy. 24(8). 841–849. 14 indexed citations
14.
Xu, Hao, Liang Huang, Wenyue Cao, et al.. (2022). Efficacy and safety of chimeric antigen receptor T-cell therapy targeting CD19/CD22 in refractory/relapsed transformed aggressive B-cell lymphoma. Cytotherapy. 25(2). 185–191. 2 indexed citations
15.
16.
17.
Huang, Liang, Na Wang, Yang Cao, et al.. (2018). CAR22/19 Cocktail Therapy for Patients with Refractory/Relapsed B-Cell Malignancies. Blood. 132(Supplement 1). 1408–1408. 20 indexed citations
18.
Shang, Zhen, Di Wang, Ming Xiao, et al.. (2012). [Detection of isocitrate dehydrogenase 1 gene mutation in 205 AML patients and its clinical significance].. PubMed. 20(6). 1307–11. 1 indexed citations
19.
Wu, Ying, Min Xiao, Li Zhu, et al.. (2011). [CD96 expression on bone marrow mononuclear cells in 91 patients with acute leukemia].. PubMed. 19(3). 585–8. 2 indexed citations
20.
Li, Chunrui, et al.. (2010). The Isolation Technology of Oil And Gas Pipeline In China. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongchang Li Breakdown of academic impact, for papers by Cuicui Li Breakdown of academic impact, for papers by Mohsen Eshraghi Breakdown of academic impact, for papers by He Liu Breakdown of academic impact, for papers by Jörg C. Gerlach Breakdown of academic impact, for papers by Lu Xu Breakdown of academic impact, for papers by Eleftherios T. Papoutsakis Breakdown of academic impact, for papers by Tao Ren Breakdown of academic impact, for papers by Guansong Wang
Rankless by CCL
2026